Differentiation of EL4 lymphoma cells by tumoral environment is associated with inappropriate expression of the large chondroitin sulfate proteoglycan PG-M and the tumor-associated antigen HTgp-175

International Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 503-510

  Rottiers, Pieter ^a   Verfaillie, Tine ^a   Contreras, Roland ^a   Revets, Hilde ^a   Desmedt, Marjory ^a   Dooms, Hans ^a   Fiers, Walter ^a   Grooten, Johan ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b Free University of Brussels ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; PROTEOGLYCAN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENICITY; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL DIFFERENTIATION; CELL LINE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOMA; MICE; MICE, INBRED C57BL; PROTEOCHONDROITIN SULFATES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VERSICANS;

EID: 0031754877     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981109)78:4<503::AID-IJC18>3.0.CO;2-6     Document Type: Article

References (23)

1. BEHRENS, J., VON KRIES, J.P., KUHL, M., BRUHN, L., WEDLICH, D., GROSSCHEDL, R. and BIRCHMEIER, W., Functional interaction of β-catenin with the transcription factor LEF-1. Nature (Lond.), 382, 638-642 (1996).
2. BROUTY-BOYÉ, D. and RAUX, H., Differential influence of stromal fibroblasts from different breast tissues on human breast tumor cell growth in nude mice. Anticancer Res., 13, 1087-1090 (1993).
3. CHISAKA, O. and CAPECCHI, M.R., Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene HOX-1.5. Nature (Lond.), 350, 473-479 (1991).
4. DESMEDT, M., ROTTIERS, P., DOOMS, H., FIERS, W. and GROOTEN, J., Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J. Immunol., 160, 5300-5308 (1998).
5. EIDELMAN, F.J., FUKS, A., DEMARTE, L., TAHERI, M. and STANNERS, C.P., Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblast. J. Cell Biol., 123, 467-475 (1993).
6. GROOTEN, J., LEROUX-ROELS, G. and FIERS, W., Specific suppression elicited by EL4 lymphoma cells in syngeneic mice. Specificity includes self-antigens on EL4. Europ. J. Immunol., 17, 605-611 (1987).
7. HART, I. and FIDLER, I., Role of organ selectivity in the determination of melastatic patterns of B16 melanoma. Cancer Res., 40, 2281-2287 (1980).
8. HERRLICH, P., ZÖLLER, M., PALS, S.T. and PONTA, H., CD44 splice variants: metastases meet lymphocytes. Immunol. Today, 14, 395-399 (1993).
9. ISOGAI, Z., SHINOMURA, T., YAMAKAWA, N., TAKEUCHI, J., TSUJI, T., HEINEGÅRD, D. and KIMATA, K., 2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. Cancer Res., 56, 3902-3908 (1996).
10. ITO, K., SHINOMURA, T., ZAKO, M., UJITA, M. and KIMATA, K., Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J. biol. Chem., 270, 958-965 (1995).
11. MARTINY-BARON, G. and MARMÉ, D., VEGF-mediated tumor angiogenesis: a new target for cancer therapy. Curr. Opin. Biotechnol., 6, 675-680 (1995).
12. MAULSECKER, C.C. and GRUSS. P., The oncogenic potential of deregulated homeobox genes. Cell Growth Differ., 4, 431-441 (1993).
13. MITANI, K., Chromosomal abnormalities and oncogenes. Int. J. Hematol., 63, 81-93 (1996).
14. PERKINS, A., KONGSUWAN, K., VISVADER, J., ADAMS, J.M. and CORY, S., Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia, Proc. nat. Acad. Sci. (Wash.), 87, 8398-8402 (1990).
15. RADINSKY, R., Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metastasis Rev., 14, 323-338 (1995).
16. RAN, M., KATZ, B., KIMCHI, N., HALACHMI, E., TEILLAUD, J.-L., EVEN, J., BERKO-FLINT, Y., ATLAS, E., FRIDMAN, W.H. and WITZ, I.P., In vivo acquisition of FcγRII expression on polyoma virus-transformed cells derived from tumors of long latency. Cancer Res., 51, 612-618 (1991).
17. SAGER, R., Expression genetics in cancer: shifting the focus from DNA to RNA. Proc. nat. Acad. Sci. (Wash.), 94, 952-955 (1997).
18. SHINOMURA, T., ZAKO, M., ITO, K., UJITA, M. and KIMATA, K., The gene structure and organization of mouse PG-M, a large chondroitin-sulfate proteoglycan. J. biol Chem., 270, 10328-10333 (1995).
19. VAN HECKE, D., VERSCHUEREN, H. and DE BAETSELIER, P., Identification of T-cell antigens expressed by metastatic T-cell hybridomas and lymphomas. Int. J. Cancer, 45, 773-782 (1990).
20. YAMAGATA, M. and KIMATA, K., Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J. Cell Sci., 107, 2581-2590 (1994).
21. YAMAGATA, M., SHINOMURA, T. and KIMATA, K., Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/ aggrecan) in chick embryos. Anat. Embryol., 187, 433-444 (1993).
22. ZHANG, L., ZHOU, W., VELCULESCU, V.E., KERN, S.E., HRUBAN, R.H., HAMILTON, S.R., VOGELSTEIN, B. and KINZLER, K.W., Gene expression profiles in normal and cancer cells. Science, 276, 1268-1272 (1997).
23. ZUSMAN, T., GOHAR, O., ELIASSI, I., AVIVI, Y., LISANSKY, E., SAUTES, C., EVEN, J., BONNEROT, C., FRIDMAN, W.H., WITZ, I.P. and RAN, M., The murine Fc-gamma (Fc-γ) receptor type II B1 is a tumorigenicity-enhancing factor in polyoma-virus-transformed 3T3 cells. Int. J. Cancer, 65, 221-229 (1996).